{
    "xml": "<topic id=\"PHP1447\" outputclass=\"drug\" rev=\"1.25\" type=\"drug\" namespace=\"/drugs/heparin-unfractionated\" basename=\"heparin-unfractionated\" title=\"HEPARIN (UNFRACTIONATED)\">\n<title>HEPARIN (UNFRACTIONATED)</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_788\" namespace=\"/interactions/list-of-drug-interactions/anticoagulants/heparins/heparin\">Heparin</xref>\n</p>\n<data name=\"vtmid\">84812008</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_502671253\" title=\"Heparins\">Heparins</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34597\" title=\"HEPARINS\" namespace=\"/drug-classes/heparins\">HEPARINS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP50031\" outputclass=\"indicationsAndDose\" rev=\"1.35\" parent=\"/drugs/heparin-unfractionated\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of mild to moderate pulmonary embolism</p>\n<p outputclass=\"therapeuticIndication\">Treatment of unstable angina</p>\n<p outputclass=\"therapeuticIndication\">Treatment of acute peripheral arterial occlusion</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Loading dose 5000&#8239;units, alternatively (by intravenous injection) loading dose 75&#8239;units/kg, followed by (by continuous intravenous infusion) 18&#8239;units/kg/hour, laboratory monitoring essential&#8212;preferably on a daily basis, and dose adjusted accordingly.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of severe pulmonary embolism</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Loading dose 10&#8239;000&#8239;units, followed by (by continuous intravenous infusion) 18&#8239;units/kg/hour, laboratory monitoring essential&#8212;preferably on a daily basis, and dose adjusted accordingly.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of deep-vein thrombosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Loading dose 5000&#8239;units, alternatively (by intravenous injection) loading dose 75&#8239;units/kg, followed by (by continuous intravenous infusion) 18&#8239;units/kg/hour, alternatively (by subcutaneous injection) 15&#8239;000&#8239;units every 12&#8239;hours, laboratory monitoring essential&#8212;preferably on a daily basis, and dose adjusted accordingly.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Thromboprophylaxis in medical patients</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5000&#8239;units every 8&#8211;12&#8239;hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Thrombophylaxis in surgical patients</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5000&#8239;units for 1 dose, to be taken 2 hours before surgery, then 5000&#8239;units every 8&#8211;12&#8239;hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Thromboprophylaxis during pregnancy</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5000&#8211;10&#8239;000&#8239;units every 12&#8239;hours, to be administered with monitoring, <b>Important</b>: prevention of prosthetic heart-valve thrombosis in pregnancy calls for <b>specialist management</b>.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Haemodialysis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 1000&#8211;5000&#8239;units, followed by (by continuous intravenous infusion) 250&#8211;1000&#8239;units/hour.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of clotting in extracorporeal circuits</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the device as a flush</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>(consult product literature).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">To maintain patency of catheters, cannulas, other indwelling intravenous infusion devices</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the device as a flush</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8211;200&#8239;units, to be flushed through every 4&#8211;8 hours, not for therapeutic use.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP50022\" outputclass=\"pregnancy\" parent=\"/drugs/heparin-unfractionated\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Does not cross the placenta; maternal osteoporosis reported after prolonged use; multidose vials may contain benzyl alcohol&#8212;some manufacturers advise avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP50147\" outputclass=\"breastFeeding\" parent=\"/drugs/heparin-unfractionated\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Not excreted into milk due to high molecular weight.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP50109\" outputclass=\"hepaticImpairment\" parent=\"/drugs/heparin-unfractionated\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Risk of bleeding increased&#8212;reduce dose or avoid in severe impairment (including oesophageal varices).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49998\" outputclass=\"renalImpairment\" parent=\"/drugs/heparin-unfractionated\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Risk of bleeding increased in severe impairment&#8212;dose may need to be reduced.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP50154\" outputclass=\"directionsForAdministration\" rev=\"1.9\" parent=\"/drugs/heparin-unfractionated\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For <i>intravenous infusion</i>, give continuously in Glucose 5% or Sodium chloride 0.9%; administration with a motorised pump is advisable.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57117\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/heparin-unfractionated\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Doses listed take into account the guidelines of the British Society for Haematology.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1447-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/heparin-unfractionated\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: eye drops, solution for injection, solution for infusion</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77449\" title=\"Solution for injection\" namespace=\"/drugs/heparin-unfractionated/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77456\" title=\"Infusion\" namespace=\"/drugs/heparin-unfractionated/infusion\">Infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77443\" title=\"Not applicable\" namespace=\"/drugs/heparin-unfractionated/not-applicable\">Not applicable</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78144\" namespace=\"/treatment-summaries/acute-coronary-syndromes\" title=\"Acute coronary syndromes\" count=\"8\" rel=\"backlink\">Acute coronary syndromes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78186\" namespace=\"/treatment-summaries/antiplatelet-drugs\" title=\"Antiplatelet drugs\" count=\"4\" rel=\"backlink\">Antiplatelet drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78403\" namespace=\"/treatment-summaries/venous-thromboembolism\" title=\"Venous thromboembolism\" count=\"8\" rel=\"backlink\">Venous thromboembolism</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78413\" namespace=\"/treatment-summaries/parenteral-anticoagulants\" title=\"Parenteral anticoagulants\" count=\"5\" rel=\"backlink\">Parenteral anticoagulants</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78504\" namespace=\"/treatment-summaries/surgery-and-long-term-medication\" title=\"Surgery and long-term medication\" count=\"1\" rel=\"backlink\">Surgery and long-term medication</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_788\" namespace=\"/interactions/list-of-drug-interactions/anticoagulants/heparins/heparin\" title=\"Heparin\" count=\"1\" rel=\"link\">Heparin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34597\" namespace=\"/drug-classes/heparins\" title=\"HEPARINS\" count=\"1\" rel=\"link\">HEPARINS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77449\" namespace=\"/drugs/heparin-unfractionated/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77456\" namespace=\"/drugs/heparin-unfractionated/infusion\" title=\"Infusion\" count=\"1\" rel=\"link\">Infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77443\" namespace=\"/drugs/heparin-unfractionated/not-applicable\" title=\"Not applicable\" count=\"1\" rel=\"link\">Not applicable</xref>\n</links>\n</topic>",
    "id": "PHP1447",
    "outputclass": "drug",
    "rev": "1.25",
    "type": "drug",
    "namespace": "/drugs/heparin-unfractionated",
    "basename": "heparin-unfractionated",
    "title": "HEPARIN (UNFRACTIONATED)",
    "interactants": [
        {
            "id": "bnf_int_788",
            "label": "Heparin"
        }
    ],
    "vtmid": "84812008",
    "drugClassification": [
        "Heparins"
    ],
    "inheritsFromClass": [
        "HEPARINS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of mild to moderate pulmonary embolism",
                        "html": "Treatment of mild to moderate pulmonary embolism"
                    },
                    {
                        "textContent": "Treatment of unstable angina",
                        "html": "Treatment of unstable angina"
                    },
                    {
                        "textContent": "Treatment of acute peripheral arterial occlusion",
                        "html": "Treatment of acute peripheral arterial occlusion"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Loading dose 5000 units, alternatively (by intravenous injection) loading dose 75 units/kg, followed by (by continuous intravenous infusion) 18 units/kg/hour, laboratory monitoring essential&#8212;preferably on a daily basis, and dose adjusted accordingly.",
                        "html": "<p>Loading dose 5000&#8239;units, alternatively (by intravenous injection) loading dose 75&#8239;units/kg, followed by (by continuous intravenous infusion) 18&#8239;units/kg/hour, laboratory monitoring essential&#8212;preferably on a daily basis, and dose adjusted accordingly.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of severe pulmonary embolism",
                        "html": "Treatment of severe pulmonary embolism"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Loading dose 10 000 units, followed by (by continuous intravenous infusion) 18 units/kg/hour, laboratory monitoring essential&#8212;preferably on a daily basis, and dose adjusted accordingly.",
                        "html": "<p>Loading dose 10&#8239;000&#8239;units, followed by (by continuous intravenous infusion) 18&#8239;units/kg/hour, laboratory monitoring essential&#8212;preferably on a daily basis, and dose adjusted accordingly.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of deep-vein thrombosis",
                        "html": "Treatment of deep-vein thrombosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Loading dose 5000 units, alternatively (by intravenous injection) loading dose 75 units/kg, followed by (by continuous intravenous infusion) 18 units/kg/hour, alternatively (by subcutaneous injection) 15 000 units every 12 hours, laboratory monitoring essential&#8212;preferably on a daily basis, and dose adjusted accordingly.",
                        "html": "<p>Loading dose 5000&#8239;units, alternatively (by intravenous injection) loading dose 75&#8239;units/kg, followed by (by continuous intravenous infusion) 18&#8239;units/kg/hour, alternatively (by subcutaneous injection) 15&#8239;000&#8239;units every 12&#8239;hours, laboratory monitoring essential&#8212;preferably on a daily basis, and dose adjusted accordingly.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Thromboprophylaxis in medical patients",
                        "html": "Thromboprophylaxis in medical patients"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "5000 units every 8&#8211;12 hours.",
                        "html": "<p>5000&#8239;units every 8&#8211;12&#8239;hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Thrombophylaxis in surgical patients",
                        "html": "Thrombophylaxis in surgical patients"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "5000 units for 1 dose, to be taken 2 hours before surgery, then 5000 units every 8&#8211;12 hours.",
                        "html": "<p>5000&#8239;units for 1 dose, to be taken 2 hours before surgery, then 5000&#8239;units every 8&#8211;12&#8239;hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Thromboprophylaxis during pregnancy",
                        "html": "Thromboprophylaxis during pregnancy"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "5000&#8211;10 000 units every 12 hours, to be administered with monitoring, Important: prevention of prosthetic heart-valve thrombosis in pregnancy calls for specialist management.",
                        "html": "<p>5000&#8211;10&#8239;000&#8239;units every 12&#8239;hours, to be administered with monitoring, <b>Important</b>: prevention of prosthetic heart-valve thrombosis in pregnancy calls for <b>specialist management</b>.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Haemodialysis",
                        "html": "Haemodialysis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 1000&#8211;5000 units, followed by (by continuous intravenous infusion) 250&#8211;1000 units/hour.",
                        "html": "<p>Initially 1000&#8211;5000&#8239;units, followed by (by continuous intravenous infusion) 250&#8211;1000&#8239;units/hour.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of clotting in extracorporeal circuits",
                        "html": "Prevention of clotting in extracorporeal circuits"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the device as a flush"
                    ],
                    "textContent": "To the device as a flush",
                    "html": "To the device as a flush"
                },
                "adult": [
                    {
                        "textContent": "(consult product literature).",
                        "html": "<p>(consult product literature).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "To maintain patency of catheters, cannulas, other indwelling intravenous infusion devices",
                        "html": "To maintain patency of catheters, cannulas, other indwelling intravenous infusion devices"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the device as a flush"
                    ],
                    "textContent": "To the device as a flush",
                    "html": "To the device as a flush"
                },
                "adult": [
                    {
                        "textContent": "10&#8211;200 units, to be flushed through every 4&#8211;8 hours, not for therapeutic use.",
                        "html": "<p>10&#8211;200&#8239;units, to be flushed through every 4&#8211;8 hours, not for therapeutic use.</p>"
                    }
                ]
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Does not cross the placenta; maternal osteoporosis reported after prolonged use; multidose vials may contain benzyl alcohol&#8212;some manufacturers advise avoid.",
                "html": "<p>Does not cross the placenta; maternal osteoporosis reported after prolonged use; multidose vials may contain benzyl alcohol&#8212;some manufacturers advise avoid.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Not excreted into milk due to high molecular weight.",
                "html": "<p>Not excreted into milk due to high molecular weight.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Risk of bleeding increased&#8212;reduce dose or avoid in severe impairment (including oesophageal varices).",
                "html": "<p>Risk of bleeding increased&#8212;reduce dose or avoid in severe impairment (including oesophageal varices).</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Risk of bleeding increased in severe impairment&#8212;dose may need to be reduced.",
                "html": "<p>Risk of bleeding increased in severe impairment&#8212;dose may need to be reduced.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion, give continuously in Glucose 5% or Sodium chloride 0.9%; administration with a motorised pump is advisable.",
                "html": "<p>For <i>intravenous infusion</i>, give continuously in Glucose 5% or Sodium chloride 0.9%; administration with a motorised pump is advisable.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Doses listed take into account the guidelines of the British Society for Haematology.",
                "html": "<p>Doses listed take into account the guidelines of the British Society for Haematology.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "eye drops",
                "solution for injection",
                "solution for infusion"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77449",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77456",
                "label": "Infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77443",
                "label": "Not applicable",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78144",
                "label": "Acute coronary syndromes",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78186",
                "label": "Antiplatelet drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78403",
                "label": "Venous thromboembolism",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78413",
                "label": "Parenteral anticoagulants",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78504",
                "label": "Surgery and long-term medication",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_788",
                "label": "Heparin",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34597",
                "label": "HEPARINS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77449",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77456",
                "label": "Infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77443",
                "label": "Not applicable",
                "type": "medicinalForm"
            }
        ]
    }
}